Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow

Implications for gene therapy

André Larochelle, Josef Vormoor, Helmut Hanenberg, Jean C Y Wang, Mickie Bhatia, Tsvee Lapidot, Thomas Moritz, Barbara Murdoch, Xiang Li Xiao, Ikunoshin Kato, David A. Williams, John E. Dick

Research output: Contribution to journalArticle

612 Citations (Scopus)

Abstract

The development of stem-cell gene therapy is hindered by the absence of repopulation assays for primitive human hematopoietic cells. Current methods of gene transfer rely on in vitro colony-forming cell (CFC) and long-term culture-initiating cell (LTC-IC) assays, as well as inference from other mammalian species. We have identified a novel human hematopoietic cell, the SCID-repopulating cell (SRC), a cell more primitive than most LTC-ICs and CFCs. The SRC, exclusively present in the CD4+CD8- fraction, is capable of multilineage repopulation of the bone marrow of nonobese diabetic mice with severe combined immunodeficiency disease (NOD/SCID mice). SRCs were rarely transduced with retroviruses, distinguishing them from most CFCs and LTC-ICs. This observation is consistent with the low level of gene marking seen in human gene therapy trials. An SRC assay may aid in the characterization of hematopoiesis, as well as the improvement of transduction methods.

Original languageEnglish
Pages (from-to)1329-1337
Number of pages9
JournalNature Medicine
Volume2
Issue number12
DOIs
StatePublished - Dec 1996

Fingerprint

Gene therapy
Forensic Anthropology
Inbred NOD Mouse
SCID Mice
Genetic Therapy
Assays
Chlorofluorocarbons
Bone
Bone Marrow
Gene transfer
Stem cells
Cell culture
Genes
Severe Combined Immunodeficiency
Hematopoiesis
Retroviridae
Cell- and Tissue-Based Therapy
Stem Cells
Cell Culture Techniques

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Larochelle, A., Vormoor, J., Hanenberg, H., Wang, J. C. Y., Bhatia, M., Lapidot, T., ... Dick, J. E. (1996). Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nature Medicine, 2(12), 1329-1337. https://doi.org/10.1038/nm1296-1329

Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow : Implications for gene therapy. / Larochelle, André; Vormoor, Josef; Hanenberg, Helmut; Wang, Jean C Y; Bhatia, Mickie; Lapidot, Tsvee; Moritz, Thomas; Murdoch, Barbara; Xiao, Xiang Li; Kato, Ikunoshin; Williams, David A.; Dick, John E.

In: Nature Medicine, Vol. 2, No. 12, 12.1996, p. 1329-1337.

Research output: Contribution to journalArticle

Larochelle, A, Vormoor, J, Hanenberg, H, Wang, JCY, Bhatia, M, Lapidot, T, Moritz, T, Murdoch, B, Xiao, XL, Kato, I, Williams, DA & Dick, JE 1996, 'Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy', Nature Medicine, vol. 2, no. 12, pp. 1329-1337. https://doi.org/10.1038/nm1296-1329
Larochelle, André ; Vormoor, Josef ; Hanenberg, Helmut ; Wang, Jean C Y ; Bhatia, Mickie ; Lapidot, Tsvee ; Moritz, Thomas ; Murdoch, Barbara ; Xiao, Xiang Li ; Kato, Ikunoshin ; Williams, David A. ; Dick, John E. / Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow : Implications for gene therapy. In: Nature Medicine. 1996 ; Vol. 2, No. 12. pp. 1329-1337.
@article{6954e4a7ea6f4e05a23b31c01ff18168,
title = "Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy",
abstract = "The development of stem-cell gene therapy is hindered by the absence of repopulation assays for primitive human hematopoietic cells. Current methods of gene transfer rely on in vitro colony-forming cell (CFC) and long-term culture-initiating cell (LTC-IC) assays, as well as inference from other mammalian species. We have identified a novel human hematopoietic cell, the SCID-repopulating cell (SRC), a cell more primitive than most LTC-ICs and CFCs. The SRC, exclusively present in the CD4+CD8- fraction, is capable of multilineage repopulation of the bone marrow of nonobese diabetic mice with severe combined immunodeficiency disease (NOD/SCID mice). SRCs were rarely transduced with retroviruses, distinguishing them from most CFCs and LTC-ICs. This observation is consistent with the low level of gene marking seen in human gene therapy trials. An SRC assay may aid in the characterization of hematopoiesis, as well as the improvement of transduction methods.",
author = "Andr{\'e} Larochelle and Josef Vormoor and Helmut Hanenberg and Wang, {Jean C Y} and Mickie Bhatia and Tsvee Lapidot and Thomas Moritz and Barbara Murdoch and Xiao, {Xiang Li} and Ikunoshin Kato and Williams, {David A.} and Dick, {John E.}",
year = "1996",
month = "12",
doi = "10.1038/nm1296-1329",
language = "English",
volume = "2",
pages = "1329--1337",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow

T2 - Implications for gene therapy

AU - Larochelle, André

AU - Vormoor, Josef

AU - Hanenberg, Helmut

AU - Wang, Jean C Y

AU - Bhatia, Mickie

AU - Lapidot, Tsvee

AU - Moritz, Thomas

AU - Murdoch, Barbara

AU - Xiao, Xiang Li

AU - Kato, Ikunoshin

AU - Williams, David A.

AU - Dick, John E.

PY - 1996/12

Y1 - 1996/12

N2 - The development of stem-cell gene therapy is hindered by the absence of repopulation assays for primitive human hematopoietic cells. Current methods of gene transfer rely on in vitro colony-forming cell (CFC) and long-term culture-initiating cell (LTC-IC) assays, as well as inference from other mammalian species. We have identified a novel human hematopoietic cell, the SCID-repopulating cell (SRC), a cell more primitive than most LTC-ICs and CFCs. The SRC, exclusively present in the CD4+CD8- fraction, is capable of multilineage repopulation of the bone marrow of nonobese diabetic mice with severe combined immunodeficiency disease (NOD/SCID mice). SRCs were rarely transduced with retroviruses, distinguishing them from most CFCs and LTC-ICs. This observation is consistent with the low level of gene marking seen in human gene therapy trials. An SRC assay may aid in the characterization of hematopoiesis, as well as the improvement of transduction methods.

AB - The development of stem-cell gene therapy is hindered by the absence of repopulation assays for primitive human hematopoietic cells. Current methods of gene transfer rely on in vitro colony-forming cell (CFC) and long-term culture-initiating cell (LTC-IC) assays, as well as inference from other mammalian species. We have identified a novel human hematopoietic cell, the SCID-repopulating cell (SRC), a cell more primitive than most LTC-ICs and CFCs. The SRC, exclusively present in the CD4+CD8- fraction, is capable of multilineage repopulation of the bone marrow of nonobese diabetic mice with severe combined immunodeficiency disease (NOD/SCID mice). SRCs were rarely transduced with retroviruses, distinguishing them from most CFCs and LTC-ICs. This observation is consistent with the low level of gene marking seen in human gene therapy trials. An SRC assay may aid in the characterization of hematopoiesis, as well as the improvement of transduction methods.

UR - http://www.scopus.com/inward/record.url?scp=16144365969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16144365969&partnerID=8YFLogxK

U2 - 10.1038/nm1296-1329

DO - 10.1038/nm1296-1329

M3 - Article

VL - 2

SP - 1329

EP - 1337

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 12

ER -